Micropapillary bladder carcinoma: A clinicopathological study of 20 cases

Journal of Urology

Volumn 161, Issue 6, 1999, Pages 1798-1802

  Johansson, S L ^a   Borghede, G ^a   Holmang S ^a  

^a NONE

Author keywords

Bladder; Bladder neoplasms; Immunohistochemistry

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER INCIDENCE; CANCER INVASION; CARCINOMA IN SITU; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TRANSITIONAL CELL CARCINOMA;

EID: 0032845605     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)68807-6     Document Type: Article

References (12)

1. Amin, M. B., Ro, J. Y., el-Sharkawy, T., Lee, K. M., Troncoso, P., Silva, E. G., Ordóñez, N. G. and Ayala, A. G.: Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary serous carcinoma. Amer. J. Surg. Path., 18: 1224, 1994.
2. Malmström, P.-U., Busch, C. and Norlen, B. J.: Recurrence, progression and survival in bladder cancer. A retrospective analysis of 232 patients with greater than or equal to 5-year followup. Scand. J. Urol. Nephrol., 21: 185, 1987.
3. Mostofi, F. K., Sobin, L. H. and Torloni, H.: Histological Typing of Urinary Bladder Tumors. Geneva: World Health Organization, 1973.
4. TNM Classification of Malignant Tumours, 4th ed. Edited by P. Hermanek and L. H. Sobin. New York: Springer Verlag, 1987.
5. Hsu, S. M., Raine, L. and Fanger, H.: Use of avidin-biotin-peroxidase complex (ABC) in immuneperoxisidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem., 29: 577, 1981.
6. Holmäng, S., Borghede, G. and Johansson, S. L.: Primary small cell carcinoma of the bladder: a report of 25 cases. J. Urol., 153: 1820, 1995.
7. Larsen, M. P., Steinberg, G. O., Brendler, C. B. and Epstein, J. L: Use of Ulex europaeus agglutinin I (UEAI) to distinguish vascular and "pseudovascular" invasion in transitional cell carcinoma of bladder with lamina propria invasion. Mod. Path., 3: 83, 1990.
8. Wang, N. P., Zee, S., Zarbo, R. J., Bacchi, C. E. and Gown, A. M.: Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl. Immunohistochem., 3: 99, 1995.
9. Miettinen, M.: Keratin 20: immunohistochemical marker for gastrointestinal, urothelial and Merkel cell carcinomas. Mod. Path., 8: 384, 1995.
10. Sheibani, K., Battifora, H., Burke, J. S. and Rappaport, H.: Leu-M1 antigen in human neoplasms. An immunohistologic study of 400 cases. Amer. J. Surg. Path., 10: 227, 1986.
11. McGuire, W. P., Hoskins, W. J., Brady, M. F., Kucera, P. R., Partridge, E. E., Look, K. Y., Clarke-Pearson, D. L. and Davidson, M.: Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. New Engl. J. Med., 334: 1, 1996.
12. Thrasher, J. B. and Crawford, E. D.: Current management of invasive and metastatic transitional cell carcinoma of the bladder. J. Urol., 149: 957, 1993.